What is the recommended duration of prednisolone (corticosteroid) therapy before considering adrenal insufficiency screening in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisolone Washout Period Before Adrenal Insufficiency Screening

Wait 48 hours after stopping prednisolone before performing the cosyntropin stimulation test to allow accurate cortisol measurement and avoid false-positive results from iatrogenic HPA axis suppression. 1

Pharmacokinetic Rationale

  • Prednisolone has a plasma half-life of only 2-4 hours, but its biological effects on HPA axis suppression persist much longer than the drug's presence in circulation 1
  • The 48-hour washout period allows prednisolone to clear sufficiently so that measured cortisol reflects endogenous adrenal function rather than exogenous steroid interference 1
  • Morning cortisol measurements in patients actively taking prednisolone are not diagnostic because the assay measures both endogenous cortisol and therapeutic steroids, with cross-reactivity varying by assay 2

Critical Testing Protocol

  • The Endocrine Society recommends never attempting diagnostic testing while the patient is actively taking prednisolone, as morning cortisol will be falsely low due to iatrogenic secondary adrenal insufficiency 1
  • After the 48-hour washout, perform the standard cosyntropin stimulation test using 0.25 mg IV or IM, with cortisol measurements at baseline and 30 minutes post-administration 1
  • A peak cortisol level of less than 500 nmol/L (18 μg/dL) at 30 minutes is diagnostic of adrenal insufficiency 1, 3

Important Safety Considerations

  • The 48-hour washout is only safe for stable outpatients—if a patient is acutely ill or unstable, immediately treat with IV hydrocortisone 100 mg without waiting for testing 1, 4
  • Treatment of suspected acute adrenal insufficiency should never be delayed for diagnostic procedures 1, 4, 3
  • Patients on more than 7.5 mg prednisolone equivalent daily for more than 3 weeks should be anticipated to have HPA axis suppression, with approximately 39-48% having adrenal insufficiency 1, 5

Alternative Approach for Chronic Steroid Users

  • For patients on chronic prednisolone who cannot safely stop for 48 hours, consider empiric glucocorticoid replacement and defer definitive testing for 3 months after switching to physiologic hydrocortisone replacement 1, 2
  • After 3 months on stable hydrocortisone maintenance therapy, perform ACTH stimulation testing to assess HPA axis recovery, prioritizing patient safety over immediate diagnostic certainty 1
  • Laboratory confirmation of adrenal insufficiency should not be attempted until corticosteroid treatment is ready to be discontinued and sufficient washout time has elapsed 2

Common Pitfalls to Avoid

  • Do not test while the patient is still on prednisolone or immediately after stopping—this will yield false-positive results showing "adrenal insufficiency" that simply reflects expected HPA suppression 2
  • Hydrocortisone must be held for 24 hours before testing, while other steroids including prednisolone require longer washout periods (48 hours minimum) 2
  • If you need to treat suspected adrenal crisis but still want to perform diagnostic testing later, use dexamethasone 4 mg IV instead of hydrocortisone, as dexamethasone does not interfere with cortisol assays 2, 6
  • In cases of long-term steroid exposure, consult endocrinology for a recovery and weaning protocol using hydrocortisone rather than attempting abrupt discontinuation and early testing 2

References

Guideline

Adrenal Insufficiency Screening and Management in Patients on Prednisolone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosing Adrenal Insufficiency in Hypo-osmolar Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Adrenal Crisis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.